UNSPSC 51433701: Treprostinil

This classification denotes a prostaglandin analogue and antihypertensive agent with the molecular formula C23H34O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RUM6K67ESG, chemically known as u-62,840 but generally known as treprostinil, which bears US NIH Compound Identifier 54786. European Medicines Agency schedules Treprostinil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21168.

UNSPSC 51433701 Treprostinil, a Commodity code, covers emergency and clinical medications supplied to state and local health and safety agencies—specifically injectable pharmaceuticals and other advanced life support drugs procured by fire departments, public health systems, and pharmacy benefit programs serving government employees and Medicaid populations. State and local governments buy these medications through sealed competitive bids, cooperative purchasing agreements, and request-for-information cycles that precede larger pharmacy network contracts. Issuing bodies include municipal fire departments, state health and human services agencies, and multistate cooperative purchasing alliances that consolidate demand across member jurisdictions. The scope includes both direct product supply—unit quantities of specific NDC-coded medications with firm expiration-date requirements and rapid delivery windows—and broader pharmacy benefit infrastructure procurement, where states and cooperative alliances solicit vendor capabilities to manage prescription fulfillment, direct-to-manufacturer relationships, and pricing models outside traditional pharmacy benefit manager and group purchasing organization channels.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department posted an IFB (26P00188) in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue with 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with a one-year contract term, two optional one-year renewals, and an estimated value of $40,000.00; the bid deadline was April 8, 2026. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 seeking vendor input on direct-to-manufacturer prescription programs and negotiated net-pricing models to inform future formal procurement. The Minnesota Department of Administration, administering the Multistate Cooperative Purchasing Alliance (MMCAP), released an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed across state and local government facilities in Minnesota and Oregon, with contract effectiveness July 1, 2026, and evaluation weighted 75 percent on price competitiveness.